PAGE research seminar April 20th 2018

The Norwegian Institute of Public Health invites you to a research seminar about the PAGE study – Early environmental influences on risk of celiac disease and type 1 diabetes. It will be held at Myrens verksted, building C, Sandakerveien 24, room “Cafétorget” on April 20th 2018. For the complete program and map for guidance, Read More »

Participation of members from Oslo Diabetes Research Centre at EASD 2017

Several abstracts by  members from  Oslo Diabetes Research Centre have been accepted for presentation at the annual EASD in Lisboa September 11-15, 2017

Read More »

Lower risk of heart failure, cardiovascular disease and overall mortality in patients with type 2 diabetes following initiation of SGLT2 inhibitors

The article Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis, recently published in Lancet Diabetes & Endocrinology,  shows that the use of sodium-glucose co-transporter-2 (SGLT2) inhibitors in normal clinical practice is associated with lower risk of heart failure, cardiovascular disease and overall mortality, compared with the use of other glucose-lowering drugs used for type 2 diabetes.

Read More »